LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Article: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites.

    Kang, Sisi / Yang, Mei / Hong, Zhongsi / Zhang, Liping / Huang, Zhaoxia / Chen, Xiaoxue / He, Suhua / Zhou, Ziliang / Zhou, Zhechong / Chen, Qiuyue / Yan, Yan / Zhang, Changsheng / Shan, Hong / Chen, Shoudeng

    Acta pharmaceutica Sinica. B

    2020  Volume 10, Issue 7, Page(s) 1228–1238

    Abstract: ... domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported ... remains unclear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding ... during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein ...

    Abstract The outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. Currently, there is no specific viral protein-targeted therapeutics. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein remains unclear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the
    Keywords covid19
    Language English
    Publishing date 2020-04-20
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2211-3835
    ISSN 2211-3835
    DOI 10.1016/j.apsb.2020.04.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book ; Online: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

    Kang, Sisi / Yang, Mei / Hong, Zhongsi / Zhang, Liping / Huang, Zhaoxia / Chen, Xiaoxue / He, Suhua / Zhou, Ziliang / Zhou, Zhechong / Chen, Qiuyue / Yan, Yan / Zhang, Changsheng / Shan, Hong / Chen, Shoudeng

    2020  

    Abstract: ... binding domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar ... binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N ... during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein ...

    Abstract The outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. Currently, there is no specific viral protein-targeted therapeutics. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein remains unclear. Herein, we have determined the 2.7 angstrom crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the beta-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2. (C) 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
    Keywords COVID-19 ; Coronavirus ; SARS-CoV-2 ; Nucleocapsid protein ; RNA binding domain ; Crystal structure ; Antiviral targeting site ; covid19
    Publishing country cn
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

    Kang, Sisi / Yang, Mei / Hong, Zhongsi / Zhang, Liping / Huang, Zhaoxia / Chen, Xiaoxue / He, Suhua / Zhou, Ziliang / Zhou, Zhechong / Chen, Qiuyue / Yan, Yan / Zhang, Changsheng / Shan, Hong / Chen, Shoudeng

    Acta pharmaceutica Sinica, 10(7):1228-1238

    2020  

    Abstract: ... domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported ... remains unclear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding ... during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein ...

    Abstract The outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. Currently, there is no specific viral protein-targeted therapeutics. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein remains unclear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the β-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.
    Keywords COVID-19 ; Antiviral targeting site ; Crystal structure ; RNA binding domain ; Nucleocapsid protein ; SARS-CoV-2 ; Coronavirus ; covid19
    Language English
    Publishing country de
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

    Sisi Kang / Mei Yang / Zhongsi Hong / Liping Zhang / Zhaoxia Huang / Xiaoxue Chen / Suhua He / Ziliang Zhou / Zhechong Zhou / Qiuyue Chen / Yan Yan / Changsheng Zhang / Hong Shan / Shoudeng Chen

    Acta Pharmaceutica Sinica B, Vol 10, Iss 7, Pp 1228-

    2020  Volume 1238

    Abstract: ... domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported ... remains unclear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding ... during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein ...

    Abstract The outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. Currently, there is no specific viral protein-targeted therapeutics. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein remains unclear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the β-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.
    Keywords COVID-19 ; Coronavirus ; SARS-CoV-2 ; Nucleocapsid protein ; RNA binding domain ; Crystal structure ; Therapeutics. Pharmacology ; RM1-950 ; covid19
    Language English
    Publishing date 2020-07-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

    Kang, Sisi / Yang, Mei / Hong, Zhongsi / Zhang, Liping / Huang, Zhaoxia / Chen, Xiaoxue / He, Suhua / Zhou, Ziliang / Zhou, Zhechong / Chen, Qiuyue / Yan, Yan / Zhang, Changsheng / Shan, Hong / Chen, Shoudeng

    bioRxiv

    Abstract: ... yet to be clear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding domain ... several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design ... of SARS-CoV-2 nucleocapsid protein. Although overall structure is similar with other reported coronavirus ...

    Abstract The outbreak of coronavirus disease (COVID-19) in China caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. It is currently no specific viral protein targeted therapeutics yet. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein is yet to be clear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although overall structure is similar with other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the β-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.
    Keywords covid19
    Publisher BioRxiv; MedRxiv; WHO
    Document type Article ; Online
    DOI 10.1101/2020.03.06.977876
    Database COVID19

    Kategorien

  6. Article ; Online: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

    Kang, Sisi / Yang, Mei / Hong, Zhongsi / Zhang, Liping / Huang, Zhaoxia / Chen, Xiaoxue / He, Suhua / Zhou, Ziliang / Zhou, Zhechong / Chen, Qiuyue / Yan, Yan / Zhang, Changsheng / Shan, Hong / Chen, Shoudeng

    Acta Pharmaceutica Sinica B

    2020  Volume 10, Issue 7, Page(s) 1228–1238

    Keywords General Pharmacology, Toxicology and Pharmaceutics ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ISSN 2211-3835
    DOI 10.1016/j.apsb.2020.04.009
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

    Kang, S. / Yang, M. / Hong, Z. / Zhang, L. / Huang, Z. / Chen, X. / He, S. / Zhou, Z. / Chen, Q. / Yan, Y. / Zhang, C. / Shan, H. / Chen, S.

    Abstract: ... several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design ... of SARS-CoV-2 nucleocapsid protein. Although overall structure is similar with other reported coronavirus ... yet to be clear. Herein, we have determined the crystal structure of the N-terminal RNA binding domain ...

    Abstract The outbreak of coronavirus disease (COVID-19) in China caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. It is currently no specific viral protein targeted therapeutics yet. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein is yet to be clear. Herein, we have determined the crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although overall structure is similar with other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the beta-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.
    Keywords covid19
    Publisher biorxiv
    Document type Article ; Online
    DOI 10.1101/2020.03.06.977876
    Database COVID19

    Kategorien

  8. Article ; Online: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

    Kang, Sisi / Yang, Mei / Hong, Zhongsi / Zhang, Liping / Huang, Zhaoxia / Chen, Xiaoxue / He, Suhua / Zhou, Ziliang / Zhou, Zhechong / Chen, Qiuyue / Yan, Yan / Zhang, Changsheng / Shan, Hong / Chen, Shoudeng

    bioRxiv

    Abstract: ... several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design ... of SARS-CoV-2 nucleocapsid protein. Although overall structure is similar with other reported coronavirus ... yet to be clear. Herein, we have determined the crystal structure of the N-terminal RNA binding domain ...

    Abstract The outbreak of coronavirus disease (COVID-19) in China caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. It is currently no specific viral protein targeted therapeutics yet. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein is yet to be clear. Herein, we have determined the crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although overall structure is similar with other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the beta-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.
    Keywords covid19
    Language English
    Publishing date 2020-03-11
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2020.03.06.977876
    Database COVID19

    Kategorien

  9. Article: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

    Acta pharmaceutica Sinica, 10(7):1228-1238

    2020  

    Abstract: ... domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported ... remains unclear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding ... during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein ...

    Abstract The outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths. Currently, there is no specific viral protein-targeted therapeutics. Viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle. However, the structural information of SARS-CoV-2 nucleocapsid protein remains unclear. Herein, we have determined the 2.7 Å crystal structure of the N-terminal RNA binding domain of SARS-CoV-2 nucleocapsid protein. Although the overall structure is similar as other reported coronavirus nucleocapsid protein N-terminal domain, the surface electrostatic potential characteristics between them are distinct. Further comparison with mild virus type HCoV-OC43 equivalent domain demonstrates a unique potential RNA binding pocket alongside the β-sheet core. Complemented by in vitro binding studies, our data provide several atomic resolution features of SARS-CoV-2 nucleocapsid protein N-terminal domain, guiding the design of novel antiviral agents specific targeting to SARS-CoV-2.
    Keywords COVID-19 ; Coronavirus ; Crystal structure ; Antiviral targeting site ; Nucleocapsid protein ; SARS-CoV-2 ; RNA binding domain
    Language English
    Document type Article
    Database Repository for Life Sciences

    More links

    Kategorien

To top